For your convenience, we have created interactive editions of several investor documents and packed them into this eKit. These interactive documents are designed for comfortable reading and easy navigation.

RSS Feeds

Date Title   11/16/09 Amgen to Present at Lazard Capital Healthcare Conference 11/12/09 Amgen to Present at 18th Annual Credit Suisse Healthcare Conference 11/05/09 Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 11/04/09 Call for Applications: The Amgen Award for Science Teaching Excellence 10/30/09 Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 10/21/09 Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49 10/19/09 Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA) 10/16/09 Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 10/15/09 Amgen Announces Webcast of 2009 Third Quarter Financial Results 09/24/09 Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer